| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |